Profile Picture
  • All
  • Search
  • Images
  • Videos
    • Shorts
  • Maps
  • News
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
Report an inappropriate content
Please select one of the options below.

Top suggestions for durvalumab

Imfinzi Durvalumab
Imfinzi
Durvalumab
2024 FDA Approval for Durvalumab
2024 FDA Approval for
Durvalumab
Imfinzi
Imfinzi
12 Weeks of Taxol
12 Weeks
of Taxol
Immundurvalumab Immunotherapy
Immundurvalumab
Immunotherapy
Immunotherapy Procedure
Immunotherapy
Procedure
CTLA-4 Inhibitor
CTLA-4
Inhibitor
AstraZeneca Price
AstraZeneca
Price
Adhesive Arachnoiditis Syndrome
Adhesive Arachnoiditis
Syndrome
Asco Gu
Asco
Gu
CTLA-4
CTLA
-4
Checkpoint Inhibitor
Checkpoint
Inhibitor
Cancer Therapy
Cancer
Therapy
Immunotherapy
Immunotherapy
Adalimumab Mechanism of Action
Adalimumab Mechanism
of Action
Tremelimumab
Tremelimumab
Imfinzi Immunotherapy
Imfinzi
Immunotherapy
CTLA-4 Antibody
CTLA-4
Antibody
Bladder Therapy
Bladder
Therapy
Cancer Drug Treatment
Cancer Drug
Treatment
Cancer Urothelial
Cancer
Urothelial
Bladder Cancer Surgery
Bladder Cancer
Surgery
Advanced Research On Durvalumab
Advanced Research On
Durvalumab
Caso Clinico Glioblastoma Epilepsia
Caso Clinico Glioblastoma
Epilepsia
Brain Tumor Survival Rate
Brain Tumor Survival
Rate
Brain Cancer
Brain
Cancer
Non Small Cell Lung Cancer
Non Small Cell
Lung Cancer
Durvalumab by Imfinzi
Durvalumab
by Imfinzi
Durvalumab Immunotherapy
Durvalumab
Immunotherapy
Survival of Lung Cancer
Survival of Lung
Cancer
Progression After Durvalumab
Progression After
Durvalumab
NSCLC
NSCLC
PD-L1
PD
-L1
NSCLC Cancer
NSCLC
Cancer
Lung Cancer Survival
Lung Cancer
Survival
New Lung Cancer Treatments
New Lung Cancer
Treatments
Durvalumab Immunotherapy Lung Cancer
Durvalumab
Immunotherapy Lung Cancer
Cancer Staging
Cancer
Staging
Stage 4 Lung Cancer Survival Rate
Stage 4 Lung Cancer
Survival Rate
Warthin Tumor Removal
Warthin Tumor
Removal
Bladder Cancer Survival Rate
Bladder Cancer
Survival Rate
Imfinzi Treatment
Imfinzi
Treatment
Stage 111 Lung Cancer Treatment
Stage 111 Lung Cancer
Treatment
Lung Nodule Size Chart
Lung Nodule
Size Chart
NSCLC Staging
NSCLC
Staging
Signet Cell Cancer Survival Rates
Signet Cell Cancer
Survival Rates
Lung Cancer Survival Rate
Lung Cancer
Survival Rate
Treatment for Non Small Cell Lung Cancer
Treatment for Non Small
Cell Lung Cancer
Chemoradiation Treatment
Chemoradiation
Treatment
Cystitis Surgery
Cystitis
Surgery
  • Length
    AllShort (less than 5 minutes)Medium (5-20 minutes)Long (more than 20 minutes)
  • Date
    AllPast 24 hoursPast weekPast monthPast year
  • Resolution
    AllLower than 360p360p or higher480p or higher720p or higher1080p or higher
  • Source
    All
    Dailymotion
    Vimeo
    Metacafe
    Hulu
    VEVO
    Myspace
    MTV
    CBS
    Fox
    CNN
    MSN
  • Price
    AllFreePaid
  • Clear filters
  • SafeSearch:
  • Moderate
    StrictModerate (default)Off
Filter
  1. Imfinzi
    Durvalumab
  2. 2024 FDA Approval for
    Durvalumab
  3. Imfinzi
  4. 12 Weeks
    of Taxol
  5. Immundurvalumab
    Immunotherapy
  6. Immunotherapy
    Procedure
  7. CTLA-4
    Inhibitor
  8. AstraZeneca
    Price
  9. Adhesive Arachnoiditis
    Syndrome
  10. Asco
    Gu
  11. CTLA
    -4
  12. Checkpoint
    Inhibitor
  13. Cancer
    Therapy
  14. Immunotherapy
  15. Adalimumab Mechanism
    of Action
  16. Tremelimumab
  17. Imfinzi
    Immunotherapy
  18. CTLA-4
    Antibody
  19. Bladder
    Therapy
  20. Cancer Drug
    Treatment
  21. Cancer
    Urothelial
  22. Bladder Cancer
    Surgery
  23. Advanced Research On
    Durvalumab
  24. Caso Clinico Glioblastoma
    Epilepsia
  25. Brain Tumor Survival
    Rate
  26. Brain
    Cancer
  27. Non Small Cell
    Lung Cancer
  28. Durvalumab
    by Imfinzi
  29. Durvalumab
    Immunotherapy
  30. Survival of Lung
    Cancer
  31. Progression After
    Durvalumab
  32. NSCLC
  33. PD
    -L1
  34. NSCLC
    Cancer
  35. Lung Cancer
    Survival
  36. New Lung Cancer
    Treatments
  37. Durvalumab
    Immunotherapy Lung Cancer
  38. Cancer
    Staging
  39. Stage 4 Lung Cancer
    Survival Rate
  40. Warthin Tumor
    Removal
  41. Bladder Cancer
    Survival Rate
  42. Imfinzi
    Treatment
  43. Stage 111 Lung Cancer
    Treatment
  44. Lung Nodule
    Size Chart
  45. NSCLC
    Staging
  46. Signet Cell Cancer
    Survival Rates
  47. Lung Cancer
    Survival Rate
  48. Treatment for Non Small
    Cell Lung Cancer
  49. Chemoradiation
    Treatment
  50. Cystitis
    Surgery
FDA Approves Durvalumab / Imfinzi for Resectable NSCLC Non-Small Cell Lung Cancer
2:43
FDA Approves Durvalumab / Imfinzi for Resectable NSCLC Non-Small …
3.3K viewsSep 12, 2024
YouTubeOncologyTube
Durvalumab - Imfinzi - All You Need to Know in 2 Minutes.
2:49
Durvalumab - Imfinzi - All You Need to Know in 2 Minutes.
2.4K viewsSep 8, 2024
YouTubePharma Guru
The impact of durvalumab on the SCLC treatment landscape
1:17
The impact of durvalumab on the SCLC treatment landscape
243 views8 months ago
YouTubeVJOncology
AEGEAN Trial: Perioperative Durvalumab for NSCLC - OncTalk Lung 2023
2:22
AEGEAN Trial: Perioperative Durvalumab for NSCLC - OncTalk …
301 viewsApr 2, 2024
YouTubeGlobal Resource for Advancing Cancer Education
Durvalumab ( Imfinzi ) for HCC
6:29
Durvalumab ( Imfinzi ) for HCC
264 viewsAug 15, 2024
YouTubePharmComm
Durvalumab FDA Approval for Bladder Cancer
2:03
Durvalumab FDA Approval for Bladder Cancer
216 viewsMay 5, 2017
YouTubeOncLive
Durvalumab with tremelimumab for untreated advanced or unresectable hepatocellular carcinoma
0:44
Durvalumab with tremelimumab for untreated advanced or unresectab…
110 views4 months ago
YouTubeNational Institute for Health and Care Excellenc…
2:31
Perioperative Durvalumab in Bladder Cancer | NEJM
1.3K viewsNov 14, 2024
YouTubeNEJM Group
4:33
Durvalumab following chemoradiotherapy improves surv…
367 viewsJun 26, 2024
YouTubeecancer
3:31
FDA D.I.S.C.O. Burst Edition: FDA approval of Imfinzi (durvalumab) f…
128 viewsApr 2, 2024
YouTubeU.S. Food and Drug Administration
See more videos
Static thumbnail place holder
More like this
Feedback
  • Privacy
  • Terms